Lung Cancer News

Benjamin Movsas , MD, has been named president-elect of the American Radium Society.

Considering the ongoing opioid epidemic in the United States, researchers confirmed that survival rates among transplantation recipients who received organs from patients who died of drug overdose were similar to survival among recipients from donors who died of other causes.

Of more than 7 million current and former heavy smokers eligible for screening, only 1.9% underwent screening in 2016, according to an analysis of national screening sites scheduled for presentation at the ASCO Annual Meeting.

The population of ever smokers in the United States chosen to be screened for lung cancer by nine risk models vary widely, according to research published in Annals of Internal Medicine.

The American Cancer Society released a position statement that cautiously accepts electronic cigarettes as less harmful than combustible tobacco products for smokers who are unwilling or unable to quit using FDA-approved cessation aids.

Assessment of depth of response adequately predicted OS and PFS for patients with metastatic non-small cell lung cancer treated with a targeted therapy or immunotherapy, according to study results.

Among aging individuals with HIV, prostate and lung cancers are expected to emerge as the most common cancer types by 2030, according to new research published in Annals of Internal Medicine.

The FDA granted priority review to atezolizumab in combination with bevacizumab and chemotherapy for the fist-line treatment of patients with metastatic nonsquamous non-small cell lung cancer.

Fruquintinib as a third- or fourth-line therapy appeared safe and superior to placebo among patients with advanced non-small cell lung cancer, according to results of a randomized, double-blind, placebo-controlled phase 2 study conducted in China.

The FDA placed a partial clinical hold on all clinical trials designed to evaluate tazemetostat, according to the drug’s manufacturer.